The Lausanne Dialogue is a series of convenings focused on identifying barriers to stopping Alzheimer’s and setting solution paths for action. It is hosted by The Global CEO Initiative on Alzheimer’s Disease in partnership with the World Economic Forum and the Davos Alzheimer’s Collaborative. This year’s focus is “ The Future of Diagnostics: Approval, Access, and Scale.” During this event, you’ll hear the perspective of Dr. Jason Karlawish, leading AD clinician & ethicist. There will be a Q&A with Dr. Karlawish after his presentation, moderated by Dr. Jeff Cummings.